125 related articles for article (PubMed ID: 11395224)
1. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?
Chen CT; Valicenti RK; Lu J; Derose T; Dicker AP; Strup SE; Mulholland SG; Hirsch IH; McGinnis DE; Gomella LG
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):591-5. PubMed ID: 11395224
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy.
Valicenti RK; Choi E; Chen C; Lu JD; Hirsch IH; Mulholland GS; Gomella LG
Urology; 2001 Apr; 57(4):769-73. PubMed ID: 11306401
[TBL] [Abstract][Full Text] [Related]
3. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
Wilder RB; Chou RH; Ryu JK; Stern RL; Wong MS; Ji M; Roach M; White RD
Am J Clin Oncol; 2000 Aug; 23(4):330-3. PubMed ID: 10955856
[TBL] [Abstract][Full Text] [Related]
4. Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial.
van der Wielen GJ; van Putten WL; Incrocci L
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):479-84. PubMed ID: 17331667
[TBL] [Abstract][Full Text] [Related]
5. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?
Valicenti RK; Winter K; Cox JD; Sandler HM; Bosch W; Vijayakumar S; Michalski J; Purdy J
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):614-20. PubMed ID: 14529764
[TBL] [Abstract][Full Text] [Related]
6. Potency preservation following stereotactic body radiation therapy for prostate cancer.
Obayomi-Davies O; Chen LN; Bhagat A; Wright HC; Uhm S; Kim JS; Yung TM; Lei S; Batipps GP; Pahira J; McGeagh KG; Collins BT; Kowalczyk K; Bandi G; Kumar D; Suy S; Dritschilo A; Lynch JH; Collins SP
Radiat Oncol; 2013 Nov; 8():256. PubMed ID: 24180317
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.
Tsai HK; Manola J; Abner A; Talcott JA; D'Amico AV; Beard C
Urol Oncol; 2005; 23(4):230-7. PubMed ID: 16018937
[TBL] [Abstract][Full Text] [Related]
8. Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy.
Merrick GS; Butler WM; Wallner KE; Murray BC; Allen Z; Galbreath RW
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):68-74. PubMed ID: 14697422
[TBL] [Abstract][Full Text] [Related]
9. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
Bruner DW; Hunt D; Michalski JM; Bosch WR; Galvin JM; Amin M; Xiao C; Bahary JP; Patel M; Chafe S; Rodrigues G; Lau H; Duclos M; Baikadi M; Deshmukh S; Sandler HM
Cancer; 2015 Jul; 121(14):2422-30. PubMed ID: 25847819
[TBL] [Abstract][Full Text] [Related]
10. Erectile dysfunction after prostate three-dimensional conformal radiation therapy. Correlation with the dose to the penile bulb.
Magli A; Giangreco M; Crespi M; Negri A; Ceschia T; De Giorgi G; Titone F; Parisi G; Fongione S
Strahlenther Onkol; 2012 Nov; 188(11):997-1002. PubMed ID: 23053160
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy.
Valicenti RK; Bissonette EA; Chen C; Theodorescu D
J Urol; 2002 Dec; 168(6):2499-504; discussion 2504. PubMed ID: 12441949
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
Mangar SA; Sydes MR; Tucker HL; Coffey J; Sohaib SA; Gianolini S; Webb S; Khoo VS; ; Dearnaley DP
Radiother Oncol; 2006 Sep; 80(3):355-62. PubMed ID: 16949694
[TBL] [Abstract][Full Text] [Related]
13. Erectile function after permanent prostate brachytherapy.
Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
[TBL] [Abstract][Full Text] [Related]
14. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
Gay HA; Sanda MG; Liu J; Wu N; Hamstra DA; Wei JT; Dunn RL; Klein EA; Sandler HM; Saigal CS; Litwin MS; Kuban DA; Hembroff L; Regan MM; Chang P; ; Michalski JM
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):304-317. PubMed ID: 28463150
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
[TBL] [Abstract][Full Text] [Related]
16. Long-term potency preservation following brachytherapy for prostate cancer.
Snyder KM; Stock RG; Buckstein M; Stone NN
BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
[TBL] [Abstract][Full Text] [Related]
19. Sexual Function After Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: Results From the Randomized Phase III HYPRO Trial.
Wortel RC; Pos FJ; Heemsbergen WD; Incrocci L
J Sex Med; 2016 Nov; 13(11):1695-1703. PubMed ID: 27665195
[TBL] [Abstract][Full Text] [Related]
20. Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.
Zelefsky MJ; Lyass O; Fuks Z; Wolfe T; Burman C; Ling CC; Leibel SA
J Clin Oncol; 1998 Oct; 16(10):3380-5. PubMed ID: 9779716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]